Skip to main content
logo
Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
9.34
+0.10 (1.08%)
May 14, 2026, 10:44 AM EDT - Market open

Ocular Therapeutix Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,0452,6211,347513217535
Market Cap Growth
56.64%94.58%162.74%136.35%-59.44%-66.00%
Enterprise Value
1,4592,6961,421398.73177.32428.02
Last Close Price
9.3412.148.544.462.816.97
PE Ratio
--8.55-7.00-4.37-2.90-7.11
PS Ratio
39.3250.4621.148.774.2112.29
PB Ratio
3.484.014.275.636.136.08
P/TBV Ratio
3.233.474.294.196.566.51
P/FCF Ratio
--12.09-9.91-6.72-3.43-8.01
P/OCF Ratio
--12.79-10.00-7.30-3.64-8.16
EV/Sales Ratio
28.0451.8922.306.823.449.83
EV/EBITDA Ratio
--10.15-8.46-5.02-2.32-5.66
EV/EBIT Ratio
--9.98-8.27-4.84-2.25-5.48
EV/FCF Ratio
--12.43-10.45-5.22-2.80-6.41
Debt / Equity Ratio
0.130.110.230.901.770.65
Debt / EBITDA Ratio
-0.27-0.29-0.45-1.05-0.84-0.78
Debt / FCF Ratio
-0.33-0.35-0.56-1.09-1.01-0.88
Net Debt / Equity Ratio
0.140.120.24-1.23-1.07-1.19
Net Debt / EBITDA Ratio
-0.27-0.29-0.451.420.501.39
Net Debt / FCF Ratio
-0.33-0.35-0.561.470.601.58
Asset Turnover
0.070.080.180.290.290.19
Inventory Turnover
1.821.992.112.472.823.60
Quick Ratio
0.510.600.786.363.947.04
Current Ratio
14.8115.3910.666.664.137.26
Return on Equity (ROE)
-47.01%-54.85%-95.21%-127.64%-115.16%-7.99%
Return on Assets (ROA)
-38.87%-42.66%-48.39%-41.05%-44.42%-33.44%
Return on Invested Capital (ROIC)
-41.36%-45.82%-77.76%-402.19%-465.70%-475.84%
Return on Capital Employed (ROCE)
-41.53%-46.01%-54.21%-49.17%-53.06%-37.72%
Earnings Yield
-14.20%-11.70%-14.29%-22.87%-34.52%-14.06%
FCF Yield
-11.78%-8.27%-10.09%-14.89%-29.19%-12.48%
Buyback Yield / Dilution
-19.87%-18.31%-84.90%-3.57%-0.59%-35.24%
Total Shareholder Return
-19.87%-18.31%-84.90%-3.57%-0.59%-35.24%
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q